SCHEMBL14633765

SCHEMBL14633765

CCOC(=O)c1cnc(SC)nc1C(=O)c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
TDP1 Q9NUW8 2/20 0.54
POLB P06746 1/20 0.54
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
MAPT P10636 5/20 0.50
HPGD P15428 2/20 0.50
TP53 P04637 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
SYK P43405 2/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
LMNA P02545 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
FOS P01100 1/20 0.44
JUN P05412 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14633635 0.89 ALDH1A1 (0.64) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633468 0.87 MEN1 (0.55) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633430 0.84 ALDH1A1 (0.54) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633122 0.83 ALDH1A1 (0.53) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14632902 0.83 ALDH1A1 (0.53) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633258 0.83 MAPK1 (0.64) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633290 0.82 KMT2A (0.54) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633165 0.82 ALDH1A1 (0.51) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633554 0.81 MAPT (0.54) ALDH1A1TDP1POLBKMT2AMEN1
SCHEMBL14633628 0.81 ALDH1A1 (0.50) ALDH1A1TDP1POLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 ALDH1A1 1308/4885TDP1 640/4885POLB 1396/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 ALDH1A1 1308/4885TDP1 640/4885POLB 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.